STOCK TITAN

Climb Bio to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Climb Bio (Nasdaq: CLYM) announced that its executive team will participate in two upcoming investor conferences in March 2025. The company will attend the TD Cowen 45th Annual Health Care Conference on March 4, 2025, at 9:50 a.m. ET, featuring a formal presentation and one-on-one investor meetings. A webcast link is provided for virtual attendance.

Additionally, Climb Bio will participate in Leerink's Global Healthcare Conference 2025 on March 10, 2025, at 10:00 a.m. ET. This event will include a fireside chat format and one-on-one investor meetings, with a webcast link also available. The announcement was made from the company's Wellesley, Massachusetts headquarters on February 25, 2025.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-2.11% News Effect

On the day this news was published, CLYM declined 2.11%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

WELLESLEY, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM) today announced that members of its executive team will participate in the upcoming investor conferences detailed below.

TD Cowen 45th Annual Health Care Conference
Format: Formal presentation and one-on-one investor meetings
Date: March 4, 2025
Time: 9:50 a.m. ET
Webcast: Click here

Leerink’s Global Healthcare Conference 2025
Format: Fireside chat and one-on-one investor meetings
Date: March 10, 2025
Time: 10:00 a.m. ET
Webcast: Click here

About Climb Bio, Inc.
Climb Bio, Inc. is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. The Company’s pipeline includes, budoprutug, an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has potential to treat a broad range of B-cell mediated diseases, and CLYM116, an anti-APRIL monoclonal antibody currently in IND-enabling studies for IgA nephropathy. For more information, please visit climbbio.com.  

Investors
Chris Brinzey
ICR Healthcare
chris.brinzey@icrhealthcare.com
339-970-2843

Media
Jon Yu
ICR Healthcare
jon.yu@icrhealthcare.com
475-395-5375


FAQ

When will Climb Bio (CLYM) present at the TD Cowen Health Care Conference in 2025?

Climb Bio will present at the TD Cowen 45th Annual Health Care Conference on March 4, 2025, at 9:50 a.m. ET.

What format will Climb Bio's presentation take at Leerink's Global Healthcare Conference 2025?

Climb Bio will participate in a fireside chat format and hold one-on-one investor meetings at Leerink's Global Healthcare Conference on March 10, 2025.

Are webcasts available for Climb Bio's (CLYM) March 2025 investor conference presentations?

Yes, webcasts are available for both conferences. Links were provided in the original announcement for virtual attendance.

How many investor conferences will Climb Bio (CLYM) attend in March 2025?

Climb Bio will attend two investor conferences in March 2025: TD Cowen's Health Care Conference on March 4 and Leerink's Global Healthcare Conference on March 10.

What types of meetings will Climb Bio executives conduct during the March 2025 conferences?

Climb Bio executives will conduct one-on-one investor meetings at both conferences, along with a formal presentation at TD Cowen and a fireside chat at Leerink.
Climb Bio

NASDAQ:CLYM

CLYM Rankings

CLYM Latest News

CLYM Latest SEC Filings

CLYM Stock Data

190.98M
67.63M
8.19%
81.77%
1.78%
Biotechnology
Pharmaceutical Preparations
Link
United States
WELLESLEY HILLS